Deep Insight into Clinical Trials for the Indian Market

A CliniExperts initiative bringing clinical trial services to india for both local and global trials.

Our Clinical trial solutions are designed to address your specific needs and deliver a smooth development pathway


Expert Clinical Research Services for Diverse Product Lines

Trusted by

Clinical Trial Management Services

Efficiently launch your product with our customised services

At CliniExperts Research Services, we focus on conducting high-quality trials in line with ethical and regulatory compliance. We aim to be your go-to Clinical Research Organization (CRO) by offering:

Whether you are a large corporate or an up-coming startup, our clinical trial solutions are designed to address your specific needs and deliver a smooth development pathway.

page main image

Therapeutics, Diagnostics & Wellness

Test products across diverse domains

Our subject-matter experts guide you through each step of your product's launch so you don't have to worry about the hassle of regulatory approvals. Our range of services spans the following categories of products

reactangle

Credentials

Our success stories to tell

Approval For 15+ FDCs
Approval For 6 months
Gastroenterology Gynaecology and Respiratory

FDCs must be based on convincing therapeutic rationalization and be carefully justified and clinically relevant. We helped our sponsor to prove the therapeutic rationale for various FDCs by conducting PIV clinical trials in India for gastroenterology, Gynaecology and Respiratory therapeutic areas

Approval For 2 Drugs

PMS/PSUR being conditioned for Market Authorization and licensing in India. The PSURs are to be submitted every six months for the first two years of the approval and for subsequent two years annually. We have conducted/conducting PMS studies for our sponsor as per “New Drugs and Clinical Trials Rule, 2019”. This has helped the sponsor to meet the prerequisites as per the regulations

Approval For 4 SNDs

To claim marketed drugs with modified or new claims including indication, route of administration, dosage and dosage form. A subsequent new drug (SNDs) approval required from CDSCO. Here, CliniExperts supported our client to conduct PIII, PIV and PMS studies as per CDSCO guidelines

Approval For 3 Drugs
Gynaecology Dermatology and Respiratory

Clinical trials for phytopharmaceutical drugs to be conducted as per applicable Rules and guidelines for new drugs. CliniExperts Research conducted three PIII clinical trials for three therapeutic conditions in India

Approval For 4 FDCs
GastroenterologyGynaecology Dermatology and Respiratory

CliniExperts has helped in conducting PII, PIII and PIV clinical trial in diversified therapeutic categories like Polycystic Ovary Syndrome (PCOS), Recurrent ascites with liver cirrhosis, Premenstrual Syndrome, Primary Dysmenorrhea and Alopecia Areata in children and adolescents

Approval For 1 Supplement
Gastroenterology

Most of the patients in intensive care unit (ICU) with impaired oral food consumption, present nutritional challenges which needs to be compensated using enteral tube feeding (ETF). We have successfully conducted safety and tolerance of nutritional supplements via tube feeding in hospitalized patients

Approval For 1 Supplement
Endocrinology

Functional food supplements has grown exponentially in India and to prove their claims, feasibility and safety evaluation studies are required. CliniExperts Research has conducted various studies to prove their claims like Glycaemic Index evaluation of product on Diabetic and Pre-diabetic population and many more

Driving Clinical Excellence: Unveiling CliniExperts' Expertise

A seamless blend of scientific expertise, operational efficiency, and unparalleled client support

Expert Articles

Medical Devices
Complete Guide to Medical Device Clinical Investigations under EU MDR 2017/745
The EU Medical Device Regulation (EU MDR 2017/745) has changed the way Medical Device manufacturers demonstrate the safety and performance of their products. Compared with the earlier Medical Device Directive (MDD), the MDR expects stronger clinical evidence to support a device’s intended purpose and claimed benefits. Earlier, manufacturers could often rely on published literature and
Clinical Trials |
Medical Devices
How Early Clinical Strategy Can Prevent Clinical Trial Delays?
One common reason for Clinical Trial delays across MDR, IVDR, FDA, and CDSCO pathways is that Clinical Trial planning starts too late. When key decisions about device design, manufacturing, or target markets have already been made, addressing clinical evidence requirements becomes more difficult, time-consuming, and costly. 1. The Real Cost of Clinical Trial Delays When
Medical Devices
Common Mistakes Medical Device Companies Make During Clinical Planning
Planning a clinical study involves much more than preparing a protocol and finding suitable study sites. There are several decisions that need attention long before the first participant is enrolled. If these decisions are rushed or overlooked, manufacturers may face unexpected costs, regulatory queries, and delays that could have been avoided with better planning. Common
Clinical Trials |
Medical Devices
Phytopharmaceutical Clinical Trials: What Makes Them Different?
Developing plant-based medicines involves bringing traditional knowledge together with modern scientific evidence. Phytopharmaceutical Clinical Trials come with their own challenges, particularly around chemical standardization, safety assessment, and regulatory compliance. Unlike crude herbal products or isolated compounds, phytopharmaceuticals are based on standardized fractions with defined active chemical markers. This makes them a distinct category that connects

Certifications and Accreditations

With these certifications, we demonstrate our dedication to quality, safety, and customer satisfaction.

ISO 9001

ISO 9001

ISO 27001

ISO 27001


*All the above fields are mandatory
contact us 2
Enquire now